Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989 Jun;27(6):823–830. doi: 10.1111/j.1365-2125.1989.tb03445.x

A stereochemical investigation of the cytotoxicity of mianserin metabolites in vitro.

R J Riley 1, C Lambert 1, N R Kitteringham 1, B K Park 1
PMCID: PMC1379810  PMID: 2757897

Abstract

1. The metabolism of the enantiomers of mianserin to stable, chemically reactive and cytotoxic metabolites by human liver microsomes has been investigated in vitro. 2. Both enantiomers were metabolised to three major oxidation products: 8-hydroxymianserin, desmethylmianserin and mianserin 2-oxide. Hydroxylation occurred more readily with the S-enantiomer, whereas desmethylmianserin was always the major metabolite of the R-enantiomer. 3. The generation of chemically reactive metabolites exhibited a marginal degree of stereoselectivity, as assessed by irreversible binding of drug to microsomal protein (S greater than or equal to R; P less than or equal to 0.05). 4. The formation of metabolites which were cytotoxic towards human mononuclear leucocytes was greater (P less than or equal to 0.001] for R(-)-mianserin than for S(+)-mianserin and showed a significant correlation with N-demethylation (r = 0.84, P less than or equal to 0.01).

Full text

PDF
823

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMADOR E., DORFMAN L. E., WACKER W. E. SERUM LACTIC DEHYDROGENASE ACTIVITY: AN ANALYTICAL ASSESSMENT OF CURRENT ASSAYS. Clin Chem. 1963 Aug;12:391–399. [PubMed] [Google Scholar]
  2. Altamura A. C., Melorio T., Invernizzi G., Gomeni R. Influence of age on mianserin pharmacokinetics. Psychopharmacology (Berl) 1982;78(4):380–382. doi: 10.1007/BF00433747. [DOI] [PubMed] [Google Scholar]
  3. Boobis A. R., Brodie M. J., Kahn G. C., Fletcher D. R., Saunders J. H., Davies D. S. Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens. Br J Clin Pharmacol. 1980 Jan;9(1):11–19. doi: 10.1111/j.1365-2125.1980.tb04790.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs. 1978 Oct;16(4):273–301. doi: 10.2165/00003495-197816040-00001. [DOI] [PubMed] [Google Scholar]
  5. Bøyum A. Separation of lymphocytes, granulocytes, and monocytes from human blood using iodinated density gradient media. Methods Enzymol. 1984;108:88–102. doi: 10.1016/s0076-6879(84)08076-9. [DOI] [PubMed] [Google Scholar]
  6. Caldwell J., Winter S. M., Hutt A. J. The pharmacological and toxicological significance of the stereochemistry of drug disposition. Xenobiotica. 1988 Jan;18 (Suppl 1):59–70. [PubMed] [Google Scholar]
  7. Chaplin S. Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part I. Adverse Drug React Acute Poisoning Rev. 1986 Summer;5(2):97–136. [PubMed] [Google Scholar]
  8. Dawling S., Ford S., Ariyanayagam P., O'Neal H., Lewis R. R. Plasma concentrations of mianserin after single dose and at steady-state in depressed elderly patients. Clin Pharmacokinet. 1987 Jan;12(1):73–78. doi: 10.2165/00003088-198712010-00005. [DOI] [PubMed] [Google Scholar]
  9. Geneve J., Larrey D., Letteron P., Descatoire V., Tinel M., Amouyal G., Pessayre D. Metabolic activation of the tricyclic antidepressant amineptine--I. Cytochrome P-450-mediated in vitro covalent binding. Biochem Pharmacol. 1987 Feb 1;36(3):323–329. doi: 10.1016/0006-2952(87)90289-9. [DOI] [PubMed] [Google Scholar]
  10. Gourlay G. K., Coulthard K. The role of naloxone infusions in the treatment of overdoses of long half-life narcotic agonists: application to nor-methadone. Br J Clin Pharmacol. 1983 Feb;15(2):269–271. doi: 10.1111/j.1365-2125.1983.tb01498.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Guengerich F. P., Liebler D. C. Enzymatic activation of chemicals to toxic metabolites. Crit Rev Toxicol. 1985;14(3):259–307. doi: 10.3109/10408448509037460. [DOI] [PubMed] [Google Scholar]
  12. Horning E. C., Thenot J. P., Helton E. D. Toxic agents resulting from the oxidative metabolism of steroid hormones and drugs. J Toxicol Environ Health. 1978 Mar-May;4(2-3):341–361. doi: 10.1080/15287397809529665. [DOI] [PubMed] [Google Scholar]
  13. Inman W. H. Blood disorders and suicide in patients taking mianserin or amitriptyline. Lancet. 1988 Jul 9;2(8602):90–92. doi: 10.1016/s0140-6736(88)90016-5. [DOI] [PubMed] [Google Scholar]
  14. Kappus H., Remmer H. Irreversible protein binding of [14-C]imipramine with rat and human liver microsomes. Biochem Pharmacol. 1975 May 15;24(10):1079–1084. doi: 10.1016/0006-2952(75)90193-8. [DOI] [PubMed] [Google Scholar]
  15. Kitteringham N. R., Lambert C., Maggs J. L., Colbert J., Park B. K. A comparative study of the formation of chemically reactive drug metabolites by human liver microsomes. Br J Clin Pharmacol. 1988 Jul;26(1):13–21. doi: 10.1111/j.1365-2125.1988.tb03358.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  17. Maguire K. P., Norman T. R., Burrows G. D., Scoggins B. A. A pharmacokinetic study of mianserin. Eur J Clin Pharmacol. 1982;21(6):517–520. doi: 10.1007/BF00542048. [DOI] [PubMed] [Google Scholar]
  18. O'Donnell J. L., Sharman J. R., Begg E. J., Colls B. M., Moller P. W. Possible mechanism for mianserin induced neutropenia associated with saturable elimination kinetics. Br Med J (Clin Res Ed) 1985 Nov 16;291(6506):1375–1376. doi: 10.1136/bmj.291.6506.1375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. OMURA T., SATO R. THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. J Biol Chem. 1964 Jul;239:2370–2378. [PubMed] [Google Scholar]
  20. Park B. K. Metabolic basis of adverse drug reactions. J R Coll Physicians Lond. 1986 Jul;20(3):195–200. [PMC free article] [PubMed] [Google Scholar]
  21. Parke D. V. Activation mechanisms to chemical toxicity. Arch Toxicol. 1987;60(1-3):5–15. doi: 10.1007/BF00296939. [DOI] [PubMed] [Google Scholar]
  22. Purba H. S., Maggs J. L., Orme M. L., Back D. J., Park B. K. The metabolism of 17 alpha-ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites. Br J Clin Pharmacol. 1987 Apr;23(4):447–453. doi: 10.1111/j.1365-2125.1987.tb03074.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Quraishy E. Erythema multiforme during treatment with mianserin-A case report. Br J Dermatol. 1981 Apr;104(4):481–481. doi: 10.1111/j.1365-2133.1981.tb15322.x. [DOI] [PubMed] [Google Scholar]
  24. Riley R. J., Maggs J. L., Lambert C., Kitteringham N. R., Park B. K. An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin. Br J Clin Pharmacol. 1988 Nov;26(5):577–588. doi: 10.1111/j.1365-2125.1988.tb05298.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Shami M., Elliott H. L., Kelman A. W., Whiting B. The pharmacokinetics of mianserin. Br J Clin Pharmacol. 1983;15 (Suppl 2):313S–322S. doi: 10.1111/j.1365-2125.1983.tb05880.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Spielberg S. P. Acetaminophen toxicity in human lymphocytes in vitro. J Pharmacol Exp Ther. 1980 May;213(2):395–398. [PubMed] [Google Scholar]
  27. Stricker B. H., Barendregt J. N., Claas F. H. Thrombocytopenia and leucopenia with mianserin-dependent antibodies. Br J Clin Pharmacol. 1985 Jan;19(1):102–104. doi: 10.1111/j.1365-2125.1985.tb02621.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Testa B. Substrate and product stereoselectivity in monooxygenase-mediated drug activation and inactivation. Biochem Pharmacol. 1988 Jan 1;37(1):85–92. doi: 10.1016/0006-2952(88)90757-5. [DOI] [PubMed] [Google Scholar]
  29. Urbain D., Rodzynek J. J., Wettendorff P., Meyer P., Delcourt A. Toxicité hépatique de la miansérine. Rev Med Brux. 1985 Jan;6(1):39–40. [PubMed] [Google Scholar]
  30. Wakeling A. Efficacy and side effects of mianserin, a tetracyclic antidepressant. Postgrad Med J. 1983 Apr;59(690):229–231. doi: 10.1136/pgmj.59.690.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. de Jongh G. D., van den Wildenberg H. M., Nieuwenhuyse H., van der Veen F. The metabolism of mianserin in women, rabbits, and rats: identification of the major urinary metabolites. Drug Metab Dispos. 1981 Jan-Feb;9(1):48–53. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES